Antibiotics and Pandemics

Industrial animal agriculture is not only a matter of animal welfare or environmental impact, but also a significant factor in global public health risks. Two central concerns stand out: the emergence of antibiotic-resistant bacteria and the risk of zoonotic diseases—illnesses that can be transmitted from animals to humans.

1. Antibiotic Use in Animal Agriculture

A substantial proportion of globally produced antibiotics is used in animal agriculture. In many countries, antibiotics are administered not only to treat sick animals, but also prophylactically or to prevent outbreaks in densely confined populations.

The World Health Organization (WHO) has repeatedly warned that widespread antibiotic use in livestock contributes to the development of resistant bacterial strains. When bacteria are repeatedly exposed to antibiotics, resistance can evolve and spread—including to humans.

2. Transmission Pathways of Resistant Bacteria

Resistant bacteria can reach humans through multiple pathways:

• direct contact with animals or farm environments,
• contaminated food products,
• environmental routes such as manure, soil, and water,
• global trade and supply chains.

The European Food Safety Authority (EFSA) and the WHO regularly document links between livestock production and resistant bacteria in humans.

Antibiotic resistance is widely regarded as one of the greatest global health threats of our time. The WHO has described it as a “silent pandemic,” as resistant infections are increasingly difficult—or sometimes impossible—to treat.

3. Zoonoses – When Pathogens Cross Species Barriers

Approximately 60–75% of emerging infectious diseases in humans are zoonotic in origin. This means they originate in animal populations. Intensive farming systems with high stocking densities, genetic uniformity, and close contact between animals and humans create conditions in which pathogens can emerge, mutate, and spread.

Examples of zoonotic diseases linked to animal production or animal trade include:

• various strains of avian influenza (Influenza A),
• swine flu (H1N1),
• SARS-related coronaviruses,
• certain Salmonella and Campylobacter infections.

While not every pandemic originates directly from livestock production, scientific literature emphasizes that land-use change, intensive animal farming, and global animal trade increase the likelihood of zoonotic spillover events.

4. Systemic Risk Factors

Several structural characteristics of industrial animal production increase health risks:

• High animal densities facilitate rapid pathogen transmission.
• Genetically homogeneous populations are more vulnerable to disease outbreaks.
• Global supply chains accelerate international spread.
• Extensive antibiotic use selects for resistant strains.

These factors are not isolated incidents but inherent features of large-scale intensive systems.

5. Economic and Societal Consequences

Antibiotic resistance and zoonotic outbreaks generate enormous economic costs: longer hospital stays, more expensive treatments, and productivity losses. The COVID-19 pandemic demonstrated how profoundly global infectious events can destabilize societies.

Although COVID-19 did not originate directly from livestock production, it highlights the systemic importance of zoonotic risks.

6. Prevention Perspective

Many expert bodies emphasize the importance of a “One Health” approach: human, animal, and environmental health are interconnected. Reducing animal populations, improving husbandry conditions, and limiting antibiotic use are widely regarded as key measures for minimizing risk.

Conclusion

The antibiotic resistance and zoonosis argument situates animal agriculture within a global health context. It concerns not only individual consumption choices, but systemic risk structures. Intensive animal farming demonstrably increases the risk of resistant bacteria and creates conditions conducive to zoonotic disease emergence. The structure of animal production therefore affects not only animals, but public health as a whole.